MediWound Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	16.96	20.22	18.69	26.5
Revenue Growth (YoY)	-16.14%	8.22%	-29.48%	-
Cost of Revenue	13.71	17.59	15.11	13.33
Gross Profit	3.25	2.63	3.58	13.17
Selling, General & Admin	14.21	13.14	11.61	10.65
Research & Development	14.32	8.88	7.47	10.18
Other Operating Expenses	-0.01	0.02	-0.21	0.68
Total Operating Expenses	28.52	22.03	18.87	21.51
Operating Income	-25.27	-19.4	-15.29	-8.35
Interest Income	4.02	2.05	10.65	0.46
Interest Expense	-2.46	-12.81	-1.89	-11.64
Other Non-Operating Income (Expense)	1.56	-10.76	8.76	-11.18
Total Non-Operating Income (Expense)	3.11	-21.53	17.52	-22.35
Pretax Income	-23.71	-30.16	-6.53	-19.52
Provision for Income Taxes	-0.17	-0.06	-0.19	-0.08
Net Income	-23.88	-30.22	-6.72	-19.6
Net Income to Common	-23.88	-30.22	-6.72	-19.6
Shares Outstanding (Basic)	11	10	9	5
Shares Outstanding (Diluted)	11	10	9	5
Shares Change (YoY)	14.23%	10.50%	80.73%	-
EPS (Basic)	-2.10	-3.03	-0.75	-3.93
EPS (Diluted)	-2.10	-3.03	-0.75	-3.93
Free Cash Flow	-21.63	-19.9	-16.93	-12.44
Free Cash Flow Per Share	-1.90	-2.00	-1.88	-2.49
Gross Margin	19.19%	13.03%	19.15%	49.69%
Operating Margin	-148.98%	-95.94%	-81.83%	-31.50%
Profit Margin	-140.80%	-149.46%	-35.94%	-73.97%
FCF Margin	-127.52%	-98.39%	-90.60%	-46.95%
EBITDA	-23.41	-17.92	-13.99	-7.07
EBITDA Margin	-138.02%	-88.60%	-74.85%	-26.69%
EBIT	-25.27	-19.4	-15.29	-8.35
EBIT Margin	-148.98%	-95.94%	-81.83%	-31.50%
Effective Tax Rate	0.71%	0.20%	2.83%	0.40%

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q